Third CECOG Consensus on the Systemic Treatment of Non-Small-Cell Lung Cancer

This is a clinical guideline that reviews systemic treatment options for adult patients with non-small-cell lung cancer. First line and maintenance recommendations are provided. The guideline also examines the use of biological markers for personalized therapy. Outcomes of interest include overall survival and adverse affects.